These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1024 related items for PubMed ID: 14696484

  • 1. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E, Panasiuk A, Siergiejczyk L, Orzechowska-Bobkiewicz A, Lewszuk A, Walecki J, Prokopowicz D.
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [Abstract] [Full Text] [Related]

  • 2. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH, Seo DW, Lee YS, Kim ST, Mun CW, Lim TH, Min YI, Suh DJ.
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [Abstract] [Full Text] [Related]

  • 3. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
    Geissler A, Lock G, Fründ R, Held P, Hollerbach S, Andus T, Schölmerich J, Feuerbach S, Holstege A.
    Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
    [Abstract] [Full Text] [Related]

  • 4. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [Abstract] [Full Text] [Related]

  • 5. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG, Nägele T, Seeger U, Hösl F, Gregor M, Kaiser S.
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [Abstract] [Full Text] [Related]

  • 6. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA, HIV MRS Consortium.
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [Abstract] [Full Text] [Related]

  • 7. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD, Unal SS, Mrazek DA, Marcus SM.
    Psychiatry Res; 2008 Feb 28; 162(2):113-21. PubMed ID: 18164911
    [Abstract] [Full Text] [Related]

  • 8. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK.
    Liver Int; 2008 Sep 28; 28(8):1095-103. PubMed ID: 18266634
    [Abstract] [Full Text] [Related]

  • 9. Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease.
    Imamura A, Miyajima H, Ito R, Orii KO.
    Neuropediatrics; 2008 Oct 28; 39(5):259-63. PubMed ID: 19294598
    [Abstract] [Full Text] [Related]

  • 10. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
    Garcia M, Huppertz HJ, Ziyeh S, Buechert M, Schumacher M, Mader I.
    Epilepsia; 2009 Mar 28; 50(3):486-92. PubMed ID: 19183221
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 28; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure.
    Gupta RK, Saraswat VA, Poptani H, Dhiman RK, Kohli A, Gujral RB, Naik SR.
    Am J Gastroenterol; 1993 May 28; 88(5):670-4. PubMed ID: 8480729
    [Abstract] [Full Text] [Related]

  • 13. [Myoinositol trends in HMRS brain spectrum of patients with hepatic encephalopathy].
    Herman-Sucharska I, Grzybek M, Grochowska A, Karcz P, Urbanik A.
    Przegl Lek; 2010 May 28; 67(4):247-50. PubMed ID: 20687354
    [Abstract] [Full Text] [Related]

  • 14. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy.
    Thuluvath PJ, Edwin D, Yue NC, deVilliers C, Hochman S, Klein A.
    Hepatology; 1995 Feb 28; 21(2):440-2. PubMed ID: 7843718
    [Abstract] [Full Text] [Related]

  • 15. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.
    Neuroimage; 2004 Apr 28; 21(4):1781-9. PubMed ID: 15050598
    [Abstract] [Full Text] [Related]

  • 16. Brain magnetic resonance spectroscopy in Tourette's disorder.
    DeVito TJ, Drost DJ, Pavlosky W, Neufeld RW, Rajakumar N, McKinlay BD, Williamson PC, Nicolson R.
    J Am Acad Child Adolesc Psychiatry; 2005 Dec 28; 44(12):1301-8. PubMed ID: 16292123
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical uses of proton magnetic resonance spectroscopy of the brain].
    Laubenberger J, Bayer S, Thiel T, Hennig J, Langer M.
    Rofo; 1998 Jun 28; 168(6):539-49. PubMed ID: 9687944
    [Abstract] [Full Text] [Related]

  • 20. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.
    Psychiatry Res; 2006 Dec 01; 148(2-3):111-20. PubMed ID: 17088051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.